Diseases, Conditions, Syndromes

Better insights into treating hepatitis C

With nearly 200 million infected people worldwide, hepatitis C virus (HCV) represents a significant public health issue. One of the most important challenges is that although the immune system seems to be responsible for ...

Diseases, Conditions, Syndromes

Cost-effective universal screening for hepatitis C in France

An estimated 75,000 people in France are unaware they are infected by hepatitis C virus. An ANRS-funded study by Sylvie Deuffic-Burban, Ph.D., a research associate at IAME (Infection, Antimicrobials, Modeling, Evolution) ...

Diseases, Conditions, Syndromes

Canada updates guidelines for hepatitis C virus infection

(HealthDay)—A guideline published in the June 4 issue of CMAJ, the journal of the Canadian Medical Association, provides updated evidence-based recommendations for the treatment of patients with chronic hepatitis C virus ...

Diseases, Conditions, Syndromes

New test allows for one-step diagnosis of HCV infection

The current standard in diagnosing Hepatitis C virus (HCV) infection requires two sequential steps that make it suboptimal, costly, inconvenient, time consuming, and globally not widely available or affordable. Now researchers ...

Diseases, Conditions, Syndromes

High sustained response rate for glecaprevir, pibrentasvir in HCV

(HealthDay)—For patients with stage 4 or 5 chronic kidney disease and hepatitis C virus (HCV) infection, 12 weeks of treatment with glecaprevir and pibrentasvir results in a high rate of sustained virologic response, according ...

Diseases, Conditions, Syndromes

AGA publishes tool to help GIs manage HCV patients

The American Gastroenterological Association (AGA) Clinical Decision Tool for the Screening and Evaluation of Hepatitis C (HCV) will help gastroenterologists in the early management of HCV-positive patients, according to ...

page 6 from 7